Literature DB >> 14507651

Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells.

Tsutomu Imai1, Akiko Horiuchi, Cuiju Wang, Kenji Oka, Satoshi Ohira, Toshio Nikaido, Ikuo Konishi.   

Abstract

Since ovarian carcinoma cells detach from the primary lesion and metastasize via peritoneal dissemination, we hypothesized that these cells are exposed to hypoxia, which may affect cell attachment and invasiveness. To address this hypothesis, we first examined in vivo the immunohistochemical expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and its topological correlation with E-cadherin expression in ovarian carcinomas. We then examined in vitro the effect of hypoxia on the mRNA and protein expressions of E-cadherin using two ovarian cancer cell lines, SKOV3 and OVCAR3, and normal ovarian surface epithelial (OSE) cells. In addition, hypoxia-induced change in the expression of SNAIL, a transcriptional factor repressing E-cadherin expression, was also analyzed. Finally, we examined the facilitation of invasiveness of ovarian cancer cells under hypoxia using Matrigel invasion assay. Immunohistochemically, nuclear localization of HIF-1alpha was observed in 32 of the 76 (42%) carcinomas studied, and showed a topological correlation with loss of E-cadherin expression. Northern blotting, real-time PCR and Western blotting demonstrated that E-cadherin expression was remarkably decreased under hypoxia in both SKOV3 and OVCAR3 cells, but not in normal OSE cells. mRNA expression of SNAIL was increased under hypoxia in both ovarian cancer cell lines. Invasion assay revealed that hypoxia increases the invasiveness of ovarian cancer cells. Accordingly, the present study demonstrated that hypoxia induces down-regulation of E-cadherin in ovarian carcinoma cells, via up-regulation of the transcriptional repressor SNAIL. These findings suggest that hypoxia plays an important role in the change in intercellular attachment, which may be involved in the initiation of tumor progression of ovarian cancer cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14507651      PMCID: PMC1868286          DOI: 10.1016/S0002-9440(10)63501-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail.

Authors:  I Poser; D Domínguez; A G de Herreros; A Varnai; R Buettner; A K Bosserhoff
Journal:  J Biol Chem       Date:  2001-04-25       Impact factor: 5.157

2.  An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.

Authors:  J S Tomlinson; M L Alpaugh; S H Barsky
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

3.  Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene.

Authors:  C W Cheng; P E Wu; J C Yu; C S Huang; C T Yue; C W Wu; C Y Shen
Journal:  Oncogene       Date:  2001-06-28       Impact factor: 9.867

4.  Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma.

Authors:  Kentaro Nakayama; Atsuko Kanzaki; Kohkichi Hata; Hidetaka Katabuchi; Hitoshi Okamura; Kohji Miyazaki; Manabu Fukumoto; Yuji Takebayashi
Journal:  Cancer Lett       Date:  2002-02-25       Impact factor: 8.679

5.  Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy.

Authors:  P Birner; M Schindl; A Obermair; G Breitenecker; G Oberhuber
Journal:  Clin Cancer Res       Date:  2001-06       Impact factor: 12.531

Review 6.  Defective E-cadherin/catenin complexes in human cancer.

Authors:  E Van Aken; O De Wever; A S Correia da Rocha; M Mareel
Journal:  Virchows Arch       Date:  2001-12       Impact factor: 4.064

7.  Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer.

Authors:  J Cai; M Ikeguchi; S Tsujitani; M Maeta; J Liu; N Kaibara
Journal:  Gastric Cancer       Date:  2001       Impact factor: 7.370

8.  Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts.

Authors:  V Vukovic; H K Haugland; T Nicklee; A J Morrison; D W Hedley
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

9.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

Authors:  H Zhong; A M De Marzo; E Laughner; M Lim; D A Hilton; D Zagzag; P Buechler; W B Isaacs; G L Semenza; J W Simons
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

10.  Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels.

Authors:  S Yamamoto; I Konishi; M Mandai; H Kuroda; T Komatsu; K Nanbu; H Sakahara; T Mori
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  130 in total

1.  Acid treatment of melanoma cells selects for invasive phenotypes.

Authors:  Raymond E Moellering; Kvar C Black; Chetan Krishnamurty; Brenda K Baggett; Phillip Stafford; Matthew Rain; Robert A Gatenby; Robert J Gillies
Journal:  Clin Exp Metastasis       Date:  2008-02-27       Impact factor: 5.150

2.  Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.

Authors:  Ni Wang; Rong Jiang; Jun-Yan Yang; Cui Tang; Lei Yang; Man Xu; Qi-Feng Jiang; Zhi-Min Liu
Journal:  J Mol Histol       Date:  2013-11-26       Impact factor: 2.611

3.  Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.

Authors:  Ji Hee Ha; Jeremy D Ward; Rangasudhagar Radhakrishnan; Muralidharan Jayaraman; Yong Sang Song; Danny N Dhanasekaran
Journal:  Oncotarget       Date:  2016-06-21

4.  A three-dimensional in vitro model of tumor cell intravasation.

Authors:  Seema M Ehsan; Katrina M Welch-Reardon; Marian L Waterman; Christopher C W Hughes; Steven C George
Journal:  Integr Biol (Camb)       Date:  2014-06       Impact factor: 2.192

5.  Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis.

Authors:  Chi-Hung Huang; Wen-Hao Yang; Shyue-Yih Chang; Shyh-Kuan Tai; Cheng-Hwei Tzeng; Jung-Yie Kao; Kou-Juey Wu; Muh-Hwa Yang
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

Review 6.  Inflammation: a driving force speeds cancer metastasis.

Authors:  Yadi Wu; Binhua P Zhou
Journal:  Cell Cycle       Date:  2009-10-03       Impact factor: 4.534

7.  Severe neonatal anemia increases intestinal permeability by disrupting epithelial adherens junctions.

Authors:  Krishnan MohanKumar; Kopperuncholan Namachivayam; Nithya Sivakumar; Natascha G Alves; Venkataramana Sidhaye; Jayanta K Das; Yerin Chung; Jerome W Breslin; Akhil Maheshwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-02-24       Impact factor: 4.052

8.  DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.

Authors:  Nilotpal Roy; Prashant V Bommi; Uppoor G Bhat; Shaumick Bhattacharjee; Indira Elangovan; Jing Li; Krushna C Patra; Dragana Kopanja; Adam Blunier; Richard Benya; Srilata Bagchi; Pradip Raychaudhuri
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

9.  Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer.

Authors:  K Lundgren; B Nordenskjöld; G Landberg
Journal:  Br J Cancer       Date:  2009-10-20       Impact factor: 7.640

10.  Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma.

Authors:  Y Kato; M Yashiro; S Noda; M Tendo; S Kashiwagi; Y Doi; T Nishii; J Matsuoka; Y Fuyuhiro; O Shinto; T Sawada; M Ohira; K Hirakawa
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.